Proposed Rule2025-15792
Evonik Corporation; Filing of Food Additive Petition (Animal Use)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 19, 2025
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA or we) is announcing that we have filed a food additive petition, submitted by Evonik Corporation, proposing that we amend our food additive regulations to provide for the safe use of Bacillus velezensis as a source of viable microorganism in animal food for all species.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 158 (Tuesday, August 19, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 158 (Tuesday, August 19, 2025)]
[Proposed Rules]
[Page 40269]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-15792]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 573
[Docket No. FDA-2025-F-3070]
Evonik Corporation; Filing of Food Additive Petition (Animal Use)
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification of petition.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing
that we have filed a food additive petition, submitted by Evonik
Corporation, proposing that we amend our food additive regulations to
provide for the safe use of Bacillus velezensis as a source of viable
microorganism in animal food for all species.
DATES: The food additive petition was filed on July 18, 2025.
ADDRESSES: For access to the docket to read background documents or
comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and insert the
docket number found in brackets in the heading of this document into
the ``Search'' box and follow the prompts, and/or go to the Dockets
Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Megan Hall, Center for Veterinary
Medicine, Food and Drug Administration, 5001 Campus Drive, College
Park, MD 20740, 301-796-3801, <a href="/cdn-cgi/l/email-protection#0d40686a6c6323456c61614d6b696c2365657e236a627b"><span class="__cf_email__" data-cfemail="eaa78f8d8b84c4a28b8686aa8c8e8bc4828299c48d859c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under section 409(b)(5) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 348(b)(5)), we are giving notice that
we have filed a food additive petition (FAP 2321), submitted by Evonik
Corporation, 1701 Barrett Lakes Blvd. NW, Suite 340, Kennesaw, GA
30144. The petition proposes that we amend our food additive
regulations in 21 CFR part 573--Food Additives Permitted in Feed and
Drinking Water of Animals, to provide for the safe use of Bacillus
velezensis as a source of viable microorganism in animal food for all
species.
The petitioner has claimed that this action is categorically
excluded under 21 CFR 25.32(r) because it is of a type that does not
individually or cumulatively have a significant effect on the human
environment. In addition, the petitioner has stated that, to their
knowledge, no extraordinary circumstances exist that may significantly
affect the quality of the human environment. If FDA determines a
categorical exclusion applies, neither an environmental assessment nor
an environmental impact statement is required. If FDA determines a
categorical exclusion does not apply, we will request an environmental
assessment and make it available for public inspection.
Dated: August 14, 2025.
Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2025-15792 Filed 8-18-25; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 19, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.